“Partnering with Genesis Therapeutics presents a unique opportunity to leverage their AI technologies to accelerate the ...

Stanford University genetics professor Dr. Stanley Cohen paid $29.2 million to settle a lawsuit over misleading claims he made about Nuredis Inc., his now-dissolved biotechnology company.

Local biotechnology firms then match public funding ... About 50 miles south of San Francisco in Palo Alto, Stanford is also expanding its biomedical/bioscience research with the “Bio-X ...

A prominent genetics professor at Stanford University in the US has paid $29 million to investors in Nuredis – a biotech that has now been wound up – after a California court found he ...

Biotechnology has enormous potential to solve ... Before founding TeselaGen, Mike Fero, Nathan Hillson, and Abeliuk were working at Stanford University, spending a lot of time on tasks that ...

Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.

The new doors AI and machine learning are opening to scientists undoubtedly will invite weighty ethical and moral questions ...

The broad field of biotechnology and applied microbiology covers topics on the manipulation of living organisms to make products or solve problems to meet human needs. Students in this field study ...

For decades, the U.S. biotech industry has thrived in hubs such as Boston-Cambridge and the San Francisco Bay Area, fueled by ...

Director of the US-Asia Technology Management Center at Stanford University; Marietta Wu, Managing Director of Quan Capital; and Mika Nishimura, Operational Partner of Glide Healthcare. Dr. Kelly ...